Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 9 years
- Director since
- 2023
9 years of board service in total across 3 boards, counting each seat separately. Longest: Crescent Biopharma Inc., 3 years.
Crescent Biopharma Inc.
Director
Novavax Inc.
Director
Fulcrum Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 13, 2024 | Novavax Inc. | Open-market sale | −4,150 | $9.02 | $37,433 |
| Jun 12, 2024 | Novavax Inc. | Option exercise | +6,670 | — | — |
| Mar 29, 2024 | Crescent Biopharma Inc. | Grant or award | +3,334 | $3.00 | $10,002 |
| Dec 29, 2023 | Crescent Biopharma Inc. | Grant or award | +4,238 | $2.36 | $10,002 |
| Sep 30, 2023 | Crescent Biopharma Inc. | Grant or award | +6,667 | $1.50 | $10,001 |
| Jun 10, 2023 | Novavax Inc. | Option exercise | +3,100 | — | — |
| Aug 2, 2022 | Crescent Biopharma Inc. | Inheritance | +7,500 | — | — |
| Feb 15, 2022 | Crescent Biopharma Inc. | Inheritance | +11,641 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.